{"title":"The use of brigatinib in the treatment of ALK-positive NSCLC in the progression of crizotinib","authors":"S.Y. Krutelev, К. Laktionov","doi":"10.31917/2402194","DOIUrl":null,"url":null,"abstract":"non-small cell lung cancer, ALK translocation, brigatinib, resistance","PeriodicalId":101072,"journal":{"name":"Reports of Practical Oncology","volume":"85 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Practical Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31917/2402194","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
